Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target |
Mechanism CD7 modulators(T-cell antigen CD7 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adult Lymphoblastic Lymphoma | Phase 2 | IT | 21 Apr 2024 | |
T-cell acute lymphoblastic leukemia in relapse | Phase 2 | IT | 21 Apr 2024 |
NCT06064903 (EHA2024) Manual | Phase 1/2 | 7 | (uxxlkrjopt) = rurlgljwig xkxcdgnjpo (bbpmmqqlhf ) View more | Positive | 14 May 2024 |